Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


HIMA technology adoption study

This article was originally published in The Gray Sheet

Executive Summary

Rand Health is selected by the Health Industry Manufacturers Association to conduct a study on the adoption of new medical technology in managed care settings. Expected to be complete by late fall, the study will identify how managed care organizations currently review and pay for technology, and how device firms prepare for this process. The study "may reveal voluntary 'best practices' for introducing emerging technologies into the managed care environment," HIMA says

You may also be interested in...

Rand Corp.

"Managed Care and the Evaluation and Adoption of Emerging Technology" study is scheduled for release March 21. The study is intended to provide tips on how medical device manufacturers prepare for device evaluation and coverage decisions by managed care organizations. Sponsors of the study include the California Goldstrike Partnership of the State of California's Trade and Commerce Agency, the Economic Development Administration of the U.S. Department of Commerce, and the Health Industry Manufacturers Association (1"The Gray Sheet" May 24, 1999, In Brief)

Sun's Halol Site Faces FDA Action

FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts